Mind Medicine (MindMed)
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MNMD and other ETFs, options, and stocks.About MNMD
Mind Medicine (MindMed), Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L.
CEORobert Barrow
CEORobert Barrow
Employees74
Employees74
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2010
Founded2010
Employees74
Employees74
MNMD Key Statistics
Market cap484.70M
Market cap484.70M
Price-Earnings ratio-6.34
Price-Earnings ratio-6.34
Dividend yield—
Dividend yield—
Average volume1.52M
Average volume1.52M
High today$13.25
High today$13.25
Low today$12.36
Low today$12.36
Open price$12.97
Open price$12.97
Volume1.42M
Volume1.42M
52 Week high$14.43
52 Week high$14.43
52 Week low$4.70
52 Week low$4.70
Stock Snapshot
With a market cap of 484.7M, Mind Medicine (MindMed)(MNMD) trades at $12.55. The stock has a price-to-earnings ratio of -6.34.
On 2025-12-09, Mind Medicine (MindMed)(MNMD) stock traded between a low of $12.36 and a high of $13.25. Shares are currently priced at $12.55, which is +1.6% above the low and -5.3% below the high.
The Mind Medicine (MindMed)(MNMD)'s current trading volume is 1.42M, compared to an average daily volume of 1.52M.
In the last year, Mind Medicine (MindMed)(MNMD) shares hit a 52-week high of $14.43 and a 52-week low of $4.70.
In the last year, Mind Medicine (MindMed)(MNMD) shares hit a 52-week high of $14.43 and a 52-week low of $4.70.
Analyst ratings
100%
of 12 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own MNMD. This list is generated using Robinhood data, and it’s not a recommendation.